ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Biological activity, Molecular Docking Studies and Molecular Dynamics Simulations of 2,3,4,5-Tetrahydro-1H-pyrido[4,3-b] indoles as c-Met inhibitors

Ye Lianbao*; Wu Jie; Yang Jiebo; Chen Weiqiang; Luo Yan; Zhang Yanmei广东药学院
LATIN AMERICAN JOURNAL OF PHARMACY2016
3阅读
引用收藏
分享

摘要

c-Met has been deregulated in many cancers and become one of the leading molecular targets in cancer. In our previous research, we designed and synthesized six novel 2,3,4,5-tetrahydro-1H-pyrido[4,3-b] indoles as c-Met inhibitors. In this study, we evaluated their biological activity at cellular and molecular level. The results showed that the majority of the compounds exhibited significant inhibitory effect on c-Met with IC50 values of 0.0145-0.5 mu M in TR-FRET-based assay and IC50 values of 1.34-34 mu M in cell-based assay. Furthermore, our docking experiments analyzed the results and explained the molecular mechanism of eminent activities to c-Met and molecular dynamics simulations method was then applied to perform further evaluation of the binding stabilities between the compounds 4a, 5a and their receptor 3dkf.

学科与关键词

关键词
biological activityc-Met inhibitorsmolecular dockingmolecular dynamics simulationsmolecular mechanism2,3,4,5-tetrahydro-1H-pyrido[4,3-b] indoles
相关
加载中…
  • Design and Synthesis of Some Novel 2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indoles as Potential c-Met Inhibitors
    Ye Lianbao; Tian Yuanxin; Li Zhonghuang; Zhang Jiajie*; Wu ShuguangHelvetica Chimica Acta, 2012, 95(2): 320-326.被引 7
  • Discovering potent inhibitors against c-Met kinase: molecular design, organic synthesis and bioassay
    Liang Zhongjie; Ding Xiao; Ai Jing; Kong Xiangqian; Chen Limin; Chen Liang; Luo Cheng*; Geng Meiyu; Liu Hong; Chen Kaixian; Jiang HualiangOrganic and Biomolecular Chemistry, 2012, 10(2): 421-430.被引 7
  • Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met
    Damghani, Tahereh; Moosavi, Fatemeh; Khoshneviszadeh, Mehdi; Mortazavi, Motahareh; Pirhadi, Somayeh; Kayani, Zahra; Saso, Luciano; Edraki, Najmeh*; Firuzi, Omidreza*Scientific Reports, 2021, 11(1): 3644.被引 31
查看全部 →

发表信息

论文状态
公开发表
期刊
LATIN AMERICAN JOURNAL OF PHARMACY
发表日期
2016
卷期
第 35 卷, 第 2 期
页码
416-420
语言
SPANISH
期刊等级
Q4
成果收录
SCI
资助标注
Guangdong Provincial Department of Science and Technology [2012A080800012]; Department of Science and Technology [GYFYLH201317]; First Affiliated Hospital of Guangdong Pharmaceutical University [GYFYLH201317]; Guangdong Natural Science Foundation [2015A030313586]; Science and Technology Planning Project of Guangdong Province (Guangdong Branch Regulations) [[2015]110]

作者

  • Y

    Ye Lianbao (通讯) (第一作者)

    guangdong pharmaceut univ

  • W

    Wu Jie

    guangdong pharmaceut univ

查看全部 6 位作者收起作者
  • Y

    Yang Jiebo

    guangdong pharmaceut univ

  • C

    Chen Weiqiang

    guangdong pharmaceut univ

  • L

    Luo Yan

    guangdong pharmaceut univ

  • Z

    Zhang Yanmei

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417